Core Viewpoint - On October 16, 2025, United Imaging Healthcare (688271) closed at 147.66 yuan, down 0.47%, with a turnover rate of 0.51% and a trading volume of 42,100 lots, amounting to 625 million yuan [1] Trading Information Summary - On October 16, the net outflow of main funds was 20.93 million yuan, accounting for 3.35% of the total transaction amount; the net inflow of retail funds was 8.74 million yuan, accounting for 1.4% of the total transaction amount [2] Company Announcement Summary - On October 14, 2025, United Imaging Healthcare held its 24th meeting of the second board of directors, approving the grant of 528,700 restricted stocks to 36 incentive objects at a price of 94.92 yuan per share. The grant price was adjusted to 94.79 yuan per share due to a cash dividend distribution of 1.30 yuan per 10 shares [3][5] - The board's remuneration and assessment committee confirmed that the incentive objects met the qualifications and conditions set forth in relevant laws and regulations, and the grant was approved unanimously by all directors [3][4] - The legal opinion from Shanghai Tongli Law Firm confirmed that the procedures for the restricted stock incentive plan were properly followed, and the adjustments made were in compliance with regulations [4][6] Restricted Stock Incentive Plan Details - The restricted stock incentive plan involves 528,700 shares, with the adjusted grant price set at 94.79 yuan per share. The adjustment was made following the company's semi-annual dividend distribution [5][6] - The incentive objects include 16 domestic employees and 20 foreign employees, with the total grant representing 0.06% of the company's total share capital. No individual incentive object received more than 1% of the total share capital [6][7] - The vesting schedule for the granted shares is divided into three phases: 30% after 12 months, 30% after 24 months, and 40% after 36 months [7]
股市必读:联影医疗(688271)10月16日主力资金净流出2092.74万元,占总成交额3.35%